Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.32 AUD | +5.15% | +7.51% | -4.25% |
05:49am | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bearish |
Resistance | 16.18 | 18.09 | 16.83 |
Spread/Res. | -5.32% | -15.31% | -8.97% |
Spread/Supp. | +16.06% | +16.06% | +14.84% |
Support | 13.20 | 13.20 | 13.34 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CUV Stock
- Charts Clinuvel Pharmaceuticals Limited